RICHARD STIGLIANO: Open Payments
NPI 1902802069 · HERMITAGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 57 payments from 19 companies in 2025. Trend: 2023 $1,124 · 2024 $1,501 · 2025 $1,379
Food & beverage: $1,374Education: $5
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $197 |
| ABBVIE INC. | 7 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $154 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $137 |
| Novo Nordisk Inc | 6 | $115 |
| PFIZER INC. | 5 | $108 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| Exact Sciences Corporation | 3 | $63 |
| Orexo US, Inc. | 3 | $61 |
| Esperion Therapeutics, Inc. | 2 | $45 |
Products named: UBRELVY, Kerendia, JARDIANCE, NURTEC ODT, FARXIGA, BREZTRI, Ozempic, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
